Christopher Carrier’s Post

HLB Insight: New California Proposed Law Would Require Attorney General Consent for Private Equity Healthcare Transactions (AB 3129) Written by Michael Shimada, Robert F. Miller, and Stephanie Gross Read it here: https://bit.ly/3UWdC2p #healthlaw #privateequity #healthcaretransactions

California Assembly Bill 3129, introduced in February 2024, aims to curb consolidation in the health care industry allegedly driven by private equity firms and hedge funds. If enacted, the bill would require private equity groups and hedge funds to obtain prior written consent from California's Attorney General (AG) before acquiring control of a health care facility or provider group doing at least a "substantial part" of their business in California. The bill would impact transactions entered into on or after January 1, 2025, but its passage is not guaranteed, as it must pass out of the Judiciary Committee. https://lnkd.in/eb857tE3 #healthcare #PrivateEquity #HealthcareRegulations

Upcoming Webinar Alert: Developments in Fair Market Value and Stark Law/Anti-Kickback Statute Enforcement Join us for an informative webinar hosted by the Practising Law Institute (PLI), focusing on key updates in Fair Market Value and enforcement of the Stark Law and Anti-Kickback Statute. This session is ideal for legal professionals, healthcare administrators, and compliance officers. 📅 Date: May 14, 2024 🕒 Time: 1PM EST 🌍 Location: Online – accessible from your location. Featured Speakers: Sean McKenna: Sean has over 25 years of experience in healthcare and white-collar legal practice, including extensive work with CMS, OIG, and DOJ. He is a noted speaker and recognized for his deep knowledge of healthcare law. Adam Klein: With over 20 years in the healthcare industry, Adam specializes in mergers, acquisitions, and regulatory compliance. He has a broad background in guiding healthcare transactions and strategic transformations. Webinar Highlights: Gain insights from experienced professionals Sean McKenna and Adam Klein. Participate in an interactive Q&A session. Take away practical strategies applicable to your practice. This webinar will provide you with the latest updates and strategies for navigating healthcare regulations effectively. For more details and to register, click here: https://lnkd.in/egGjpwgb #HealthcareCompliance #StarkLaw #AntiKickback #LegalEducation #PLI

Need some CLE? Jump on this webinar about Stark and Anti-Kickback enforcement.

🤝 Our Approach: What We Offer to You and Your Patients At Bush & Bush Law Group, we don’t just represent clients in the courtroom—we advocate for their well-being throughout the recovery process. For #medicalproviders, this means having a trusted legal partner who ensures patients receive the compensation needed for the right medical treatment. 1. Initial Consultation We begin every case by understanding the unique needs of each patient and providing a compassionate consultation that clarifies their legal rights and options. 2. Case Evaluation Our team conducts a thorough case evaluation, gathering evidence and setting realistic expectations, so patients feel supported and informed from the start. 3. Strategy Development We develop a custom legal strategy based on the patient's specific circumstances, aiming to secure the financial resources they need to focus on recovery. 4. Action & Negotiation Taking care of all legal filings and negotiations, we ensure patients can prioritize their health while we advocate for their fair compensation. 5. Ongoing Client Support We maintain consistent communication with patients, addressing their questions and keeping them updated so they feel assured throughout the process. 6. Medical Collaboration Partnering closely with medical providers like you, we ensure that every patient receives comprehensive support—helping them physically, financially, and emotionally. 7. Settlement Negotiations / Trial Preparation Whether through negotiation or trial, we’re dedicated to securing outcomes that relieve patients’ financial stress and help them focus on healing. 8. Client-Centric: Resolution & Satisfaction With a strong resolution, we provide closure that allows patients to move forward with confidence, knowing they’ve received justice and advocacy every step of the way. You can be confident in referring your patients to our law firm! With our legal team, you will #seethedifference we make by how well we treat them like family, ensuring transparency and support throughout the process. 💯 🌟 Together, we can help patients achieve a complete recovery – both physically and financially. 👉 Read our client testimonials: 🔗 https://bit.ly/40y7XCv #bushlawgrp #personalinjurylaw #CharlesJBush #Texas #lawyer

Charles Honart has garnered two 2024 JD Supra Readers’ Choice Awards in the areas of Health Care and M&A as a result of his insightful authorship on the firm's Health Law Observer blog. He is among JD Supra's 10 most widely-read authors in the #HealthCare category from a pool of more than 10,000 authors, and in the #MergersAndAcquisitions category from a pool of more than 3,200 authors. Well-deserved, Charles! #healthlaw

We get a lot of doctors asking how to buy and sell their practice. Here are my top tips: (1) Know what your practice is worth. It's sometimes expensive to get a valuation firm, but they really are important. You need to understand from a practical perspective what you can get for your practice. It helps you avoid the overwhelm on what to charge, and it puts things in perspective. Some doctors think they will get millions for a small solo practice in a rural area, and are disappointed when they can't find that deal. Others aren't charging enough. Everyone needs to know what they can practically get for their business. (2) Find a good healthcare attorney BEFORE you negotiate the letter of intent. While these documents are not legally binding, they are the road map for the entire deal. If you agree to something in there, thinking it's some intro document that doesn't matter, you will be held to it later. I've had clients say "oh, we negotiate when we get the legal contracts, and this letter has no effect. It does matter. It binds you to terms that your lawyers will need to stick with later, so negotiate the letter of intent before you sign it. (3) Know the cost of legal fees. It's not cheap to create a robust plan to buy or sell a practice. It involves a lot of legal work, from the asset purchase documents to the lease reviews to the due diligence to the employment agreements. There are often transition agreements, real estate sales, contract assignment issues, and more. Expect that you're going to spend about 1-5% of the deal price on legal fees. If there is real estate involved, it's more complex. (4) It takes anywhere from 45-120 days to close a deal. If it's super easy and it's clean and there is no real estate and everyone is on board and it's small dollars, I've closed one in 30 days, but that's rare. Usually there are hiccups. The more you know! Call us if you're in Texas. www.hillhealthlaw.com

"Fiscal year 2023 saw a record number of #FCA settlements and judgments (543) and civil investigative demands (1,504), with US$2.7 billion recovered by DOJ.1 The FCA allows for #trebledamages and penalties, creating massive exposure in these cases and major payments for the government and #relators. #Healthcare has consistently represented the largest focus of enforcement under the FCA and has accounted for the highest recovery. On the heels of this record year, #DOJ announced in February that #privateequity involvement in the healthcare sector will be a priority moving forward...even if private equity firms are not themselves submitting claims to the government, their actions may still subject them to #liability under the FCA...On 11 June 2024, Massachusetts Senators Ed Markey and Elizabeth Warren introduced the #CorporateCrimesAgainstHealthCareAct, aimed specifically at private equity investors in the healthcare industry...#TevaPharmaceuticals violated the #AKS and FCA by issuing over US$350 million in payments to two charities and contracted vendors to cover #Medicare copay obligations for a particular drug. The government alleged that by subsidizing the cost of the drug, patients were incentivized to purchase the drug, resulting in higher #prices for wholesalers, and ultimately yielding greater revenue for Teva. " #UnitedStatesvTevaPharmsUSAInc https://lnkd.in/eRVixCk5

Knobbe Martens partners Sean Murray and Jeremiah Helm authored “The Fed. Circ. In October: Aetna And License-Term Review,” the latest in an ongoing article series spotlighting recent Federal Circuit cases, published by Law360. In the article, the authors examine the outcome of a recent ruling in AlexSam Inc. v. Aetna Inc. — which they argue “serves as a warning to licensees that believe their agreement protects them from being sued for infringing the patent.” Read the full article here: https://lnkd.in/gNuAp-Ea #KnobbeMartens #IPLaw #FederalCircuit